QT IMAGING HOLDINGS INC
QTINASDAQTrading Snapshot
- Day Range
- $2.86 – $2.93
- 52-Week Range
- $2.62 – $19.05
- Volume
- $2.62B
- Avg Volume
- $2.11B
- Shares Outstanding
- 13.8M
- Next Earnings
- Oct 5, 2026
Fundamentals Snapshot
- Annual Revenue
- $19M
- Last Q Revenue
- $7M
- P/E Ratio
- —
- P/S Ratio
- 1.8x
- EPS (TTM)
- $-1.25
- Dividend Yield
- —
Why Investors Own QTI
- ✓High-growth profile — revenue up +47.1% YoY with expanding US Equity exposure.
- ✓Healthy economics — 66% gross margin and 12% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About QT IMAGING HOLDINGS INC
QT Imaging Holdings, Inc. is dedicated to the research, development, and manufacturing of advanced automated systems for breast imaging. These innovative devices are engineered to generate high-resolution ultrasound images utilizing transmission technology. The company's core product, the QT Ultrasound Breast Scanner, offers comprehensive reflection-mode and transmission-mode visualization of a patient's breast tissue. Established in 2011, QT Imaging Holdings, Inc. maintains its headquarters in Novato, California.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
QT Imaging Appoints Medical Imaging and Digital Health Executive Dr. Julia Albright as Chief Science Officer
NOVATO, Calif., July 29, 2026--QT Imaging Holdings, Inc. (Nasdaq: QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced the appointment of Julia Albright, Ph.D., as Chief Science Officer ("CSO"), effective July 27, 2026.
QT Imaging Holdings Announces Results of 2026 Annual Stockholder Meeting
NOVATO, Calif., July 28, 2026--QT Imaging Holdings, Inc. ("QT Imaging" or the "Company") (NASDAQ: QTI), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, announced today that at the Annual Meeting of Company’s stockholders (the "Annual Meeting") held on July 28, 2026, the Company’s stockholders voted to approve (i) the election of Professor Zeev Weiner and Bryan Timm as Class II directors to serve until the Company’
QT Imaging Receives Israeli Ministry of Health Regulatory Registration
NOVATO, Calif., July 28, 2026--QT Imaging Holdings, Inc. (Nasdaq: QTI) ("QT Imaging" or the "Company"), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that the Israeli Ministry of Health has granted registration for the Company's scanner, authorizing commercialization of the system in Israel through February 2, 2028. The approval is based on the Company's existing U.S. FDA clearance and applicable
QT Imaging Receives Israeli Regulatory Approval For Breast Acoustic CT Scanner Through February 2, 2028
Regulatory approval enables commercialization of QT Imaging's technology in Israel and supports expansion of clinical research collaborationsQT Imaging Holdings, Inc.(NASDAQ:QTI) ("QT Imaging" or the